ATTO 8-K 2026-09-02

Attovia Therapeutics, Inc. (ATTO) 8-K dated 2026-09-02 — accession 0001193125-26-380215.

Attovia Therapeutics, Inc. (ATTO) common stock.

Attovia Therapeutics, Inc. filed a 8-K on 2026-09-02. Accession 0001193125-26-380215.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ATTO revenue for 2026-06-30 was $450.0K. Net income was -$20.7M. ATTO currently screens at market cap $721.7M.

Not investment advice. The ATTO SEC hub lists recent forms. The stock page is the research view.